P Alperstein

532 total citations
9 papers, 410 citations indexed

About

P Alperstein is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, P Alperstein has authored 9 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Microbiology. Recurrent topics in P Alperstein's work include Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Medical Device Sterilization and Disinfection (2 papers) and Antibiotic Resistance in Bacteria (2 papers). P Alperstein is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Medical Device Sterilization and Disinfection (2 papers) and Antibiotic Resistance in Bacteria (2 papers). P Alperstein collaborates with scholars based in United States. P Alperstein's co-authors include Henry D. Isenberg, Eileen Hilton, R F D'Amato, Leonid Heifets, A C Niles, P R Murray, Ernestine M. Vellozzi, Miriam A. Smith, L Hochstein and Katherine France and has published in prestigious journals such as Annals of Internal Medicine, Journal of Clinical Microbiology and The Laryngoscope.

In The Last Decade

P Alperstein

9 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Alperstein United States	8	153	127	120	105	105	9	410
Jean-Pierre Lepargneur France	12	203 1.3×	31 0.2×	228 1.9×	113 1.1×	148 1.4×	20	431
Angela Whiley United Kingdom	8	163 1.1×	53 0.4×	141 1.2×	51 0.5×	98 0.9×	11	413
V. Talwar India	12	255 1.7×	171 1.3×	33 0.3×	66 0.6×	98 0.9×	35	518
Surinder Kumar India	12	342 2.2×	93 0.7×	174 1.4×	69 0.7×	51 0.5×	47	590
Júlia Hermes Germany	11	150 1.0×	281 2.2×	54 0.5×	37 0.4×	161 1.5×	22	585
Stefan Weichert Germany	11	193 1.3×	174 1.4×	26 0.2×	56 0.5×	98 0.9×	23	588
Marsha Cox United States	5	500 3.3×	39 0.3×	83 0.7×	65 0.6×	135 1.3×	8	654
Zeynel Abidin Yargıç Türkiye	8	102 0.7×	115 0.9×	46 0.4×	71 0.7×	70 0.7×	12	319
H. I. Winner United Kingdom	14	245 1.6×	325 2.6×	42 0.3×	58 0.6×	65 0.6×	33	617
Shehla H. Naqvi United States	10	80 0.5×	186 1.5×	31 0.3×	106 1.0×	22 0.2×	21	396

Countries citing papers authored by P Alperstein

Since Specialization

Citations

This map shows the geographic impact of P Alperstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Alperstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Alperstein more than expected).

Fields of papers citing papers by P Alperstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Alperstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Alperstein. The network helps show where P Alperstein may publish in the future.

Co-authorship network of co-authors of P Alperstein

This figure shows the co-authorship network connecting the top 25 collaborators of P Alperstein. A scholar is included among the top collaborators of P Alperstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Alperstein. P Alperstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Alperstein, P, et al.. (1999). In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with β-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia. Diagnostic Microbiology and Infectious Disease. 33(2). 81–86. 36 indexed citations

Isenberg, Henry D., et al.. (1998). In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin. Diagnostic Microbiology and Infectious Disease. 32(2). 115–118. 7 indexed citations

Isenberg, Henry D., P Alperstein, & Katherine France. (1997). Response of enteric gram-negative bacteria to disks containing 20 micrograms each of ampicillin and sulbactam. Journal of Clinical Microbiology. 35(2). 523–524. 1 indexed citations

Smith, Miriam A., P Alperstein, Katherine France, Ernestine M. Vellozzi, & Henry D. Isenberg. (1996). Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test. Journal of Clinical Microbiology. 34(4). 1024–1026. 25 indexed citations

Abramson, Allan L., et al.. (1993). Microbial adherence to and disinfection of laryngoscopes used in office practice. The Laryngoscope. 103(5). 503–508. 17 indexed citations

Hilton, Eileen, et al.. (1992). Ingestion of Yogurt Containing Lactobacillus acidophilus as Prophylaxis for Candidal Vaginitis. Annals of Internal Medicine. 116(5). 353–357. 215 indexed citations

Isenberg, Henry D., R F D'Amato, Leonid Heifets, et al.. (1991). Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. Journal of Clinical Microbiology. 29(8). 1719–1722. 59 indexed citations

D'Amato, R F, et al.. (1991). Evaluation of the Roche Septi-Chek AFB system for recovery of mycobacteria. Journal of Clinical Microbiology. 29(12). 2906–2908. 24 indexed citations

Isenberg, Henry D., et al.. (1988). Evaluation of three disinfectants after in-use stress. Journal of Hospital Infection. 11(3). 278–285. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact